These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17904826)

  • 1. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: a pilot investigation comparing treatment responders and non-responders.
    Mohamed MA; Smith MA; Schlund MW; Nestadt G; Barker PB; Hoehn-Saric R
    Psychiatry Res; 2007 Nov; 156(2):175-9. PubMed ID: 17904826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients.
    Sumitani S; Harada M; Kubo H; Ohmori T
    Psychiatry Res; 2007 Jan; 154(1):85-92. PubMed ID: 17208418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder.
    Fitzgerald KD; Moore GJ; Paulson LA; Stewart CM; Rosenberg DR
    Biol Psychiatry; 2000 Feb; 47(3):174-82. PubMed ID: 10682215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of distinct neural systems in patients with obsessive-compulsive disorder with autogenous and reactive obsessions.
    Besiroglu L; Sozen M; Ozbebit O; Avcu S; Selvi Y; Bora A; Atli A; Unal O; Bulut MD
    Acta Psychiatr Scand; 2011 Aug; 124(2):141-51. PubMed ID: 21627621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites.
    Tükel R; Aydın K; Ertekin E; Özyıldırım SŞ; Barburoğlu M
    Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):219-26. PubMed ID: 25256264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls.
    Mirza Y; O'Neill J; Smith EA; Russell A; Smith JM; Banerjee SP; Bhandari R; Boyd C; Rose M; Ivey J; Renshaw PF; Rosenberg DR
    J Child Neurol; 2006 Feb; 21(2):106-11. PubMed ID: 16566872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging.
    Rosenberg DR; Amponsah A; Sullivan A; MacMillan S; Moore GJ
    J Child Neurol; 2001 Sep; 16(9):636-41. PubMed ID: 11575601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential long-term effects of MDMA on the basal ganglia-thalamocortical circuit: a proton MR spectroscopy and diffusion-tensor imaging study.
    Liu HS; Chou MC; Chung HW; Cho NY; Chiang SW; Wang CY; Kao HW; Huang GS; Chen CY
    Radiology; 2011 Aug; 260(2):531-40. PubMed ID: 21633053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder.
    Jang JH; Kwon JS; Jang DP; Moon WJ; Lee JM; Ha TH; Chung EC; Kim IY; Kim SI
    Am J Psychiatry; 2006 Jul; 163(7):1202-7. PubMed ID: 16816225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.
    Auer DP; Wilke M; Grabner A; Heidenreich JO; Bronisch T; Wetter TC
    Schizophr Res; 2001 Oct; 52(1-2):87-99. PubMed ID: 11595395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopy in pediatric obsessive-compulsive disorder: longitudinal study before and after treatment.
    Lázaro L; Bargalló N; Andrés S; Falcón C; Morer A; Junqué C; Castro-Fornieles J
    Psychiatry Res; 2012 Jan; 201(1):17-24. PubMed ID: 22281202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
    Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR
    Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine.
    Ho Pian KL; van Megen HJ; Ramsey NF; Mandl R; van Rijk PP; Wynne HJ; Westenberg HG
    Psychiatry Res; 2005 Feb; 138(2):89-97. PubMed ID: 15766633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial MR imaging and 1H-MR spectroscopy in monozygotic twins with Tay-Sachs disease.
    Imamura A; Miyajima H; Ito R; Orii KO
    Neuropediatrics; 2008 Oct; 39(5):259-63. PubMed ID: 19294598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for reduced neuronal integrity in the anterior cingulate.
    Tükel R; Aydın K; Ertekin E; Özyıldırım SŞ; Taravari V
    Psychiatry Res; 2014 Dec; 224(3):275-80. PubMed ID: 25241042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parietal white matter abnormalities in obsessive-compulsive disorder: a magnetic resonance spectroscopy study at 3-Tesla.
    Kitamura H; Shioiri T; Kimura T; Ohkubo M; Nakada T; Someya T
    Acta Psychiatr Scand; 2006 Aug; 114(2):101-8. PubMed ID: 16836597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder.
    Ohara K; Isoda H; Suzuki Y; Takehara Y; Ochiai M; Takeda H; Igarashi Y; Ohara K
    Psychiatry Res; 1999 Dec; 92(2-3):83-91. PubMed ID: 10674362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia.
    Fujimoto T; Nakano T; Takano T; Takeuchi K; Yamada K; Fukuzako T; Akimoto H
    Biol Psychiatry; 1996 Jul; 40(1):14-8. PubMed ID: 8780850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.